Differences in the resting platelet proteome and platelet releasate between healthy children and adults

Journal of Proteomics

Volumn 123, Issue , 2015, Pages 78-88

  Cini, Charmaine ^a   Yip, Christina ^a,b   Attard, Chantal ^a   Karlaftis, Vasiliki ^a   Monagle, Paul ^a,b   Linden, Matthew ^c   Ignjatovic, Vera ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Platelet proteome; Platelet releasate; Platelets; Serotransferrin; Thrombospondin; Two dimensional differential in gel electrophoresis (2D DIGE)

Indexed keywords

CALPONIN; CALPONIN 2; CHORIONIC GONADOTROPIN; FIBRINOGEN; FIBRINOGEN ALPHA CHAIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN; PROTEOME; SEROTRANSFERRIN; SERUM ALBUMIN; SH3 DOMAIN PROTEIN 1; THROMBOSPONDIN 1; TRANSFERRIN; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG; PLASMA PROTEIN; THROMBOSPONDIN;

ADULT; AGING; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; GENE ONTOLOGY; HUMAN; MASS SPECTROMETRY; NORMAL HUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; AGE; CHEMISTRY; CLUSTER ANALYSIS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PH; PRESCHOOL CHILD; THROMBOCYTE ACTIVATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGE FACTORS; AGING; BLOOD PLATELETS; BLOOD PROTEINS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; HYDROGEN-ION CONCENTRATION; MASS SPECTROMETRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATION; PROTEOME; THROMBOSPONDINS; TRANSFERRIN;

EID: 84928128313     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.04.003     Document Type: Article

References (34)

1. Rae M.J., Butler R.N., Campisi J., de Grey A.D.N.J., Finch C.E., Gough M., et al. The demographic and biomedical case for late-life interventions in aging. Sci Transl Med 2010, 2(40). [p. 40cm21.].
2. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998, 158(6):585-593.
3. Ignjatovic V., Lai C., Summerhayes R., Mathesius U., Tawfilis S., Perugini M.A., et al. Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS One 2011, 6(2):e17213.
4. Zufferey A., Fontana P., Reny J.L., Nolli S., Sanchez J.C. Platelet proteomics. Mass Spectrom Rev 2012, 31(2):331-351.
5. Weyrich A.S., Schwertz H., Kraiss L.W., Zimmerman G.A. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009, 7(2):241-246.
6. Camire R.M., Pollak E.S., Kaushansky K., Tracy P.B. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998, 92(9):3035-3041.
7. Pallister C.J. Haematology 2011, Scion Publishing, UK. 2nd ed. C.J. Pallister (Ed.).
8. García A.S. Platelet proteomics: principles, analysis and applications. Wiley series on mass spectrometry. Wiley Series on Mass Spectrometry 2011, John Wiley & Sons, New Jersey, U.S.A. A. García, Y. Sensis (Eds.).
9. Coppinger J.A., Fitzgerald D.J., Maguire P.B. Isolation of the platelet releasate. Methods Mol Biol 2007, 357:307-311.
10. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103(6):2096-2104.
11. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009, 72(1):91-109.
12. Burkhart J.M., Gambarayan S., Radau S., Walter U., Martens L., Geiger J., et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012, 120(15):73-82.
13. Veitinger M., Umlauf E., Baumgartner R., Badrnya S., Porter J., Lamont J., et al. A combined proteomic and genetic analysis of the highly variable platelet proteome: from plasmatic proteins and SNPs. J Proteomics 2012, 75(18):5848-5860.
14. Winkler W., Diestinger M., Babeluk R., Marchetti M., Goll A., Zehetmayer S., et al. Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol Cell Proteomics 2008, 7(1):193-203.
15. Della Corte A., Tamburelli C., Crescente M., Giordano L., D'Imperio M., Di Michele M., et al. Platelet proteome in healthy volunteers who smoke. Platelets 2012, 23(2):91-105.
16. Banfi C., Brioschi M., Marenzi G., De Metrio M., Camera M., Mussoni L., et al. Proteome of platelets in patients with coronary artery disease. Exp Hematol 2010, 38(5):341-350.
17. Parguiña A.F., Grigorian-Shamagian L., Agra R.M., Lopez-Otero D., Rosa I., Alonso J., et al. Variations in platelet proteins associated with ST-elevation myocardial infarction: novel clues on pathways underlying platelet activation in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2011, 31(12):2957-2964.
18. Yip C., Ignjatovic V., Attard C., Monagle P., Linden M. First report of elevated monocyte-platelet aggregates in healthy children. PLoS One 2013, 8(6):e67416.
19. Yip C., Linden M., Attard C., Monagle P., Ignjatovic V. Platelets from children are hyper-responsive to activation by thrombin receptor activator peptide and adenosine diphosphate compared to platelets from adults. Br J Haematol 2014, 10.1111/bjh.13153.
20. Attard C., van der Straaten T., Karlaftis V., Monagle P., Ignjatovic V. Developmental haemostasis: age-specific differences in the quantity of haemostasis proteins. J Thromb Haemost 2013, 11:1850-1854.
21. García A. Two-dimensional gel electrophoresis in platelet proteomics research. Methods Mol Med 2007, 139:339-353.
22. hevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1(6):2856-2860.
23. Parguiña A.F., Rosa I., García A. Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets. J Proteomics 2012, 76:275-286.
24. Zaslavsky A., Baek K.H., Lynch R.C., Short S., Grillo J., Folkman J., et al. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 2010, 115(22):4605-4613.
25. Willoughby S., Holmes A., Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs 2002, 1(4):273-288.
26. Tedgui A., Mallat Z. Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease. Circ Res 2002, 90(11):1145-1146.
27. Kohanna F.H., Smith M.H., Salzman E.W. Do patients with thromboembolic disease have circulating platelet aggregates?. Blood 1984, 64(1):205-209.
28. Nesbitt W.S., Westein E., Tovar-Lopez F.J., Tolouei E., Mitchell A., Fu J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15(6):665-673.
29. Isenberg J.S., Romeo M.J., Yu C., Yu C.K., Nghiem K., Monsale J., et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 2008, 111(2):613-623.
30. Radziwon-Balicka A., Santos-Martinez M.J., Corbalan J.J., O'Sullivan S., Treumann A., Gilmer J.F., et al. Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin-1 in regulation of the P38MAPK-MMP-9 pathway. Carcinogenesis 2014, 35:324-332.
31. Lopez-Farre A.J., Zamorano-Leon J.J., Azcona L., Modrego J., Mateos-Caceres P.J., Gonzalez-Armengol J., et al. Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome. Proteomics 2011, 11(16):3335-3348.
32. Victor V.M., Rocha M., Sola E., Banuls C., Garcia-Malpartida K., Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009, 15(26):2988-3002.
33. Fearon I.M., Faux S.P. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009, 47(3):372-381.
34. Cocciolo A., Di Domenico F., Fiorini A., Cai J., Pierce W.M., Mecocci P., et al. Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: insights from redox proteomics. Free Radic Biol Med 2012, 53(10):1868-1876.